v3.23.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Revenues
General and administrative costs:        
Compensation to related parties, including stock-based compensation expense of $112,106 and $396,883 for the three months ended September 30, 2023 and 2022, respectively, and $669,146 and $1,160,649 for the nine months ended September 30, 2023 and 2022, respectively 356,001 643,957 1,398,042 1,963,409
Patent and licensing legal and filing fees and costs 178,012 271,163 835,362 944,789
Other costs and expenses 357,681 290,993 1,081,893 875,016
Research and development costs 132,487 272,388 749,029 895,649
Total costs and expenses 1,024,181 1,478,501 4,064,326 4,678,863
Loss from operations (1,024,181) (1,478,501) (4,064,326) (4,678,863)
Interest income 5,809 3,911 13,538 4,211
Interest expense (279) (2,119) (6,088) (5,240)
Foreign currency gain (loss) (109) (1,300) 2,102 (1,339)
Net loss $ (1,018,760) $ (1,478,009) $ (4,054,774) $ (4,681,231)
Net loss per common share basic $ (0.49) $ (0.89) $ (2.25) $ (3.01)
Net loss per common share diluted $ (0.49) $ (0.89) $ (2.25) $ (3.01)
Weighted average common shares outstanding basic 2,074,938 1,664,659 1,803,466 1,554,183
Weighted average common shares outstanding diluted 2,074,938 1,664,659 1,803,466 1,554,183

Source